Johnson & Johnson to Participate in Morgan Stanley Global Health Care Conference

NEW BRUNSWICK, N.J., Sept. 5, 2012 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley Global Health Care Conference Monday, September 10th, at the Grand Hyatt New York, 109 East 42nd Street at Grand Central, New York, NY.  Gary Pruden, Worldwide Chairman, Global Surgery Group for Johnson & Johnson will represent the company in a session scheduled at 1:15 p.m. (Eastern Time).

This broadcast will be available to interested investors and parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available shortly after the live webcast.

SOURCE Johnson & Johnson

Suggested Articles

Merck is scouting replacements for CEO Ken Frazier with a preference toward an internal candidate, Bloomberg reports.

Bluebird Bio says the launch of Zynteglo, its first gene therapy, will not occur until 2020 while it tightens up its manufacturing processes.

Riival generics makers are squashing long-running lawsuits over their own versions of Sanofi's big-selling blood thinner Lovenox.